CDK6, a new target in MLL-driven leukemia

Iléana Antony-Debré, Ulrich G. Steidl

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In this issue of Blood, Placke et al identify the cell-cycle regulator CDK6 as a promising new target in mixed lineage leukemia (MLL)-rearranged acute myeloid leukemia (AML) and show that its downregulation or pharmacological inhibition leads to growth inhibition and differentiation of MLL-driven leukemic cells.

Original languageEnglish (US)
Pages (from-to)5-6
Number of pages2
JournalBlood
Volume124
Issue number1
DOIs
StatePublished - Jul 3 2014

Fingerprint

Leukemia
Blood
Cells
Acute Myeloid Leukemia
Blood Cells
Cell Cycle
Down-Regulation
Pharmacology
Growth

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology
  • Medicine(all)

Cite this

CDK6, a new target in MLL-driven leukemia. / Antony-Debré, Iléana; Steidl, Ulrich G.

In: Blood, Vol. 124, No. 1, 03.07.2014, p. 5-6.

Research output: Contribution to journalArticle

Antony-Debré, Iléana ; Steidl, Ulrich G. / CDK6, a new target in MLL-driven leukemia. In: Blood. 2014 ; Vol. 124, No. 1. pp. 5-6.
@article{2a1adcdc0cdc4cefa65968daf9487500,
title = "CDK6, a new target in MLL-driven leukemia",
abstract = "In this issue of Blood, Placke et al identify the cell-cycle regulator CDK6 as a promising new target in mixed lineage leukemia (MLL)-rearranged acute myeloid leukemia (AML) and show that its downregulation or pharmacological inhibition leads to growth inhibition and differentiation of MLL-driven leukemic cells.",
author = "Il{\'e}ana Antony-Debr{\'e} and Steidl, {Ulrich G.}",
year = "2014",
month = "7",
day = "3",
doi = "10.1182/blood-2014-05-572917",
language = "English (US)",
volume = "124",
pages = "5--6",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - CDK6, a new target in MLL-driven leukemia

AU - Antony-Debré, Iléana

AU - Steidl, Ulrich G.

PY - 2014/7/3

Y1 - 2014/7/3

N2 - In this issue of Blood, Placke et al identify the cell-cycle regulator CDK6 as a promising new target in mixed lineage leukemia (MLL)-rearranged acute myeloid leukemia (AML) and show that its downregulation or pharmacological inhibition leads to growth inhibition and differentiation of MLL-driven leukemic cells.

AB - In this issue of Blood, Placke et al identify the cell-cycle regulator CDK6 as a promising new target in mixed lineage leukemia (MLL)-rearranged acute myeloid leukemia (AML) and show that its downregulation or pharmacological inhibition leads to growth inhibition and differentiation of MLL-driven leukemic cells.

UR - http://www.scopus.com/inward/record.url?scp=84904012909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904012909&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-05-572917

DO - 10.1182/blood-2014-05-572917

M3 - Article

C2 - 24993876

AN - SCOPUS:84904012909

VL - 124

SP - 5

EP - 6

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -